, Wildan Akasyah1
, Tri Ana Mulyati2
, Harwina Widya Astuti3
, Herminio Noronha4
, Fakhrudin Nasrul Sani5
, Hsiu-Ting Tsai6,7
1Faculty of Health, College of Nursing, Institut Ilmu Kesehatan Bhakti Wiyata Kediri, Kediri, Indonesia
2Faculty of Pharmacy, Institut Ilmu Kesehatan Bhakti Wiyata Kediri, Kediri, Indonesia
3Nurse Professional Education Study Program, Faculty of Health Sciences, Universitas Dirgantara Marsekal Suryadarma, Jakarta, Indonesia
4Faculty of Medicine and Health Science, Medical School Department, Universidade Nacional Timor Lorosa’e, Dili, Timor-Leste
5Nursing Professional Education Study Program, Faculty of Health Sciences, Duta Bangsa University Surakarta, Surakarta, Indonesia
6School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan
7Post-Baccalaureate Program in Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan
Copyright © 2026 The Korean Society for Preventive Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Conflict of Interest
The authors have no conflicts of interest associated with the material presented in this paper.
Funding
Kementerian Pendidikan Tinggi, Sains dan Teknologi, Indonesia, for the funding received (109/E5/PG.02.00.PL/2024).
Acknowledgements
The authors thank the Institut Ilmu Kesehatan Bhakti Wiyata Kediri, Taipei Medical University Universitas Dirgantara Marsekal Suryadarma, and Duta Bangsa University Surakarta for their support for this project.
Author Contributions
Conceptualization: Rias YA, Akasyah W, Mulyati TA, Astuti HW, Tsai HT. Data curation: Rias YA, Akasyah W, Mulyati TA, Astuti HW, Noronha H, Sani FN, Tsai HT. Formal analysis: Rias YA. Funding acquisition: Rias YA, Akasyah W, Mulyati TA. Methodology: Rias YA, Tsai HT. Project administration: Rias YA, Tsai HT. Visualization: Rias YA. Writing – original draft: Rias YA, Akasyah W, Mulyati TA, Astuti HW, Noronha H, Sani FN, Tsai HT. Writing – review & editing: Rias YA, Tsai HT.
| Scales | Pre-intervention | Post-intervention | Mean difference | SE | t | Effect size1 | p-value |
|---|---|---|---|---|---|---|---|
| Fasting plasma glucose | 303.90±61.16 | 287.00±60.95 | 16.42 | 0.65 | 25.17 | 0.95 | <0.001 |
| Loneliness | 7.74±0.89 | 4.94±0.89 | 2.81 | 0.17 | 16.52 | 0.90 | <0.001 |
| Health beliefs | |||||||
| Benefits | 5.77±0.96 | 9.42±1.26 | −3.65 | 0.28 | −13.00 | 0.85 | <0.001 |
| Severity | 8.52±0.93 | 5.48±0.77 | 3.03 | 0.20 | 15.01 | 0.89 | <0.001 |
| Susceptibility | 10.87±1.89 | 6.74±1.37 | 4.13 | 0.33 | 12.50 | 0.84 | <0.001 |
| Barriers | 10.55±1.55 | 7.00±1.21 | 3.55 | 0.26 | 13.56 | 0.86 | <0.001 |
| Feasibility | Score range | Mean±SD |
|---|---|---|
| Usefulness | 4–28 | 26.55±1.50 |
| Ease of use | 4–28 | 27.32±0.79 |
| Intention to use | 5–35 | 34.03±1.74 |
| Topic | Escalation message to participant |
|---|---|
| Blood glucose level (self-reported via chatbot) | Normal: Your blood glucose is within the normal range; Well done; continue maintaining it within normal levels |
| Fasting blood glucose | Hyperglycemia (mg/dL): |
| Random blood glucose | Level 1: 180–250 |
| 2-hr postprandial | Level 2: >250 |
| At level 1, refrain from consuming rice and sugar, lower your tension levels, and take a 10- to 30-min walk around the house; Refrain from engaging in strenuous activities | |
| If you are experiencing a level 2 emergency, it is imperative that you promptly visit a health facility | |
| Hypoglycemia (mg/dL) | |
| Level 1: <70 and >54 | |
| Level 2: <54 | |
| For levels 1 and 2: (1) Make a sugar solution by dissolving 2 tablespoons of granulated sugar in 250 mL of water, then drink it; (2) Recheck your blood sugar after 15 min; (3) If it is not normal, repeat step 1; (4) Recheck blood sugar after 15 min; (5) If it is still not normal, repeat step 1; (6) Recheck blood sugar after 15 min; (7) If it is still not normal, repeat step 1; (8) Recheck blood sugar | |
| If you are experiencing persistent abnormal blood sugar, it is imperative that you promptly visit a health facility | |
| Adherence to taking medication | |
| Hello <name>, I am Ns Andi. I would like to remind you of the schedule for taking your medication. Have you taken your diabetes medication? | Yes, |
| Awesome, I am happy to hear it, stay healthy | |
| I will remind you again according to your medication schedule; Thank you | |
| No, | |
| I am sad to hear that. May I know the reason? | |
| My medicine is out of stock: | |
| Visit a health service immediately to get it | |
| I am tired of taking medicine, I have no need to take medicine, I don't believe this medicine helps, I don’t know how much I took, or another reason: a leaflet/video will be distributed | |
| Foot self-care | |
| Do you feel numbness in your feet? | Yes, |
| Okay, perform the foot exercises according to the video and leaflet | |
| No, | |
| Excellent, healthy; To minimize the risk of foot ulcer or other problems, please moisturize your feet and perform the exercises according to the video and leaflet | |
| Do you have a foot ulcer? | Yes, |
| Please visit a health facility. | |
| No, | |
| Great, to minimize the risk of foot ulcers, please perform the exercises according to the video and leaflet | |
| Psychology | |
| Do you feel loneliness, stress, or anxiety? | No, |
| Great, please read the motivation card to help maintain your psychological condition | |
| Yes, | |
| It’s okay, keep thinking positively; Please read the motivation card to support your psychological condition | |
| Nutrition status | |
| Daily caloric need; enter your weight, gender, height, and activity level | We calculate the total caloric need |
| Also, we suggest the plate/condiment/portion for the individual with diabetes (a leaflet is provided) |
| Characteristics | n (%) or mean±SD |
|---|---|
| Age (y) | 47.36±6.25 |
| Sex | |
| Female | 20 (60.6) |
| Male | 13 (39.4) |
| Marital status | |
| Not married/single/widowed | 15 (45.5) |
| Married | 18 (54.5) |
| Education level | |
| ISCED <3 | 14 (42.4) |
| ISCED ≥3 | 19 (57.6) |
| BMI (kg/m2) | 25.44±3.94 |
| Income (IDR) | |
| Low | 15 (45.5) |
| High | 18 (54.5) |
| Living situation | |
| Alone | 10 (30.3) |
| With nuclear family | 13 (39.4) |
| With extended family | 10 (30.3) |
| Internet use (hr/day) | |
| <3 | 10 (30.3) |
| ≥3 | 23 (69.7) |
| Duration of diabetes (y) | 4.42±1.77 |
| Scales | Pre-intervention | Post-intervention | Mean difference | SE | t | Effect size |
p-value |
|---|---|---|---|---|---|---|---|
| Fasting plasma glucose | 303.90±61.16 | 287.00±60.95 | 16.42 | 0.65 | 25.17 | 0.95 | <0.001 |
| Loneliness | 7.74±0.89 | 4.94±0.89 | 2.81 | 0.17 | 16.52 | 0.90 | <0.001 |
| Health beliefs | |||||||
| Benefits | 5.77±0.96 | 9.42±1.26 | −3.65 | 0.28 | −13.00 | 0.85 | <0.001 |
| Severity | 8.52±0.93 | 5.48±0.77 | 3.03 | 0.20 | 15.01 | 0.89 | <0.001 |
| Susceptibility | 10.87±1.89 | 6.74±1.37 | 4.13 | 0.33 | 12.50 | 0.84 | <0.001 |
| Barriers | 10.55±1.55 | 7.00±1.21 | 3.55 | 0.26 | 13.56 | 0.86 | <0.001 |
| Feasibility | Score range | Mean±SD |
|---|---|---|
| Usefulness | 4–28 | 26.55±1.50 |
| Ease of use | 4–28 | 27.32±0.79 |
| Intention to use | 5–35 | 34.03±1.74 |
| Theme | Detail information | Quote |
|---|---|---|
| Theme 1: Feasibility (usefulness, ease of use, and intention to use) | Users indicated that the TakonGendhis chatbot was feasible based on its usefulness, ease of use, and intention to use; Engaging the chatbot in conversation about several topics, including restorative medication, card motivation, and blood glucose monitoring, was exciting; Users observed that this feature increased engagement in the conversation | “TakonGendhis is simple and easy to use. When I first used it, I didn’t feel confused, which enabled me to find what I needed without difficulties.” [Participant 2] |
| “This chatbot gives a quick and clear answer. Finding information is easy.” [Participant 8] | ||
| “I appreciate the clear options and helpful instructions. I feel comfortable interacting with TakonGendhis.” [Participant 13] | ||
| Theme 2: Beliefs | We highlighted patient statements regarding the theme of beliefs related to checking blood sugar levels and reminders about taking medication or increasing beliefs to inject insulin independently in the following 2 statements | “I believe that by checking my blood sugar levels regularly, I can better manage my diabetes. TakonGendhis helps me feel more positive about my health.” [Participant 3] |
| “TakonGendhis helps improve medication adherence and belief, so I can self-inject insulin to prevent complications in the future.” [Participant 17] | ||
| Theme 3: Emotional support | Participants reported how TakonGendhis could offer emotional support and have a beneficial impact on their experiences | “I appreciate how TakonGendhis is always there to answer my questions whenever I need it. I receive emotional support from this chatbot, which makes me feel less alone in my health journey.” [Participant 1] |
| “This chatbot understands what I worry about and provides assistance.” [Participant 18] | ||
| Theme 4: Areas for improvement | We highlighted 2 areas for improving chatbot user experiences; First, users wanted the chatbot to remind them to take their medicine at least 3 to 4 times a day (depending on the schedule established); Second, users desired additional emoticons or infographics | “Yes, but sometimes I forget because the chatbot doesn’t always remind me to take medicine at medicine time.” [Participant 17] |
| “The explanatory text is straightforward. However, I believe that it will be more effective with the addition of emoticons or infographics.” [Participant 13] |
T2DM, type 2 diabetes mellitus; SD, standard deviation; ISCED, International Standard Classification of Education; BMI, body mass index; IDR, Indonesian Rupiah rate.
Values are presented as mean±standard deviation. T2DM, type 2 diabetes mellitus; SE, standard error. Cohen
SD, standard deviation.